Aytu BioPharma (AYTU) Earnings Analysis
Aytu BioPharma (AYTU) next reports earnings on 2026-09-22, consensus EPS -0.22 USD. Last quarter (2025-11-13) it missed with EPS -0.08 USD vs -0.06 USD est (-33.3%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -0.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AYTU next report earnings?
| Next earnings date | 2026-09-22 |
|---|---|
| Consensus EPS estimate | -0.22 USD |
| Revenue estimate | 0.02B |
AYTU earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-13 | -0.08 USD | -0.06 USD | -33.3% | Miss |
| 2025-09-23 | -0.26 USD | -0.02 USD | -1200% | Miss |
| 2024-11-13 | -0.2 USD | -0.34 USD | +41.2% | Beat |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
AYTU valuation and analyst view
| Trailing P/E | -0.50 |
|---|---|
| Trailing EPS | -3.23976 USD |
| Price / book | 0.65 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Aytu BioPharma (AYTU)'s next earnings date?
Aytu BioPharma is next scheduled to report on 2026-09-22, with a consensus EPS estimate of -0.22 USD and revenue estimate of 0.02B.
Did AYTU beat earnings last quarter?
In its 2025-11-13 report, AYTU posted EPS of -0.08 USD versus a -0.06 USD estimate — a miss of 33.3%.
What is AYTU's earnings track record?
Over the last 3 reported quarters with consensus data, AYTU beat estimates 1 times (33%).
What is AYTU's current P/E ratio and EPS?
AYTU trades at a trailing P/E of -0.50 on trailing EPS of -3.2397594158748495 USD.
What do analysts rate AYTU?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell).